Despite opposition from various organizations and agriculture
stakeholders, scientists and researchers at the Philippine Rice
Research Institute (PhilRice) will be conducting field trials
of genetically modified (GM) rice by December this year, the
International Rice Research Institute (IRRI) said. PhilRice
researchers, in collaboration with the IRRI, are now developing
a version of “golden rice,” which is engineered
to produce beta-carotene. Their effort is aimed at developing
the first commercially grown GM rice in the world.
It can be recalled that Agriculture Secretary Proceso Alcala
issued a statement opposing the commercialization of GM rice
in the country, saying that he will not allow the production
of genetically modified rice “unless it is proved safe
for human consumption.”
Alcala, the former representative of Quezon province, is also
pushing for organic agriculture and has co-authored a law that
promotes organic farming.
But since being appointed Agriculture secretary, Alcala said
he will make farmer stakeholders choose between conventional
or chemical and organic farming methods.
PhilRice Executive Director Ronilo Beronio said that the organic
farming law poses no interference with IRRI’s research
into GM rice.
“We have a regulatory system in place. The administrative
order that allows field trials and commercialization of GM crops,
as well as the AFMA [Agriculture and Fisheries Modernization
Act], which encourages biotechnology, have not been revoked.
I don’t think the organic law has been amended or superseded,”
he said.
Beronio added that PhilRice expects approval by the Bureau
of Plant Industry, which oversees field trials, on the GM rice
trials.
He said that the National Committee on Biosafety of the Philippines,
which oversees genetic engineering activities, has already allowed
confined trials, which precede field trials, both at PhilRice
and IRRI sites.
Project leader Antonio Alfonso said the December field tests
will be conducted at a single location and will last four months
during the cropping season for that period. Also, multi-location
trials for at least two cropping seasons will follow, with the
aim of commercializing the GM rice by 2012 or early 2013.
Beronio said that Alcala, who chairs PhilRice’s Board
of Trustees, will be informed of the developments at a forthcoming
meeting where it will be argued that field trials are necessary
for a thorough scientific evaluation of the crop’s safety.
If commercialized, the Philippines, now the world’s largest
rice importer, would again lead developing countries in bringing
a GM crop to the market. In 2002, the country was the first
in Asia to commercialize a transgenic crop, Bt (Bacillus thuringiensis)
corn, for animal feed and food.
Beronio said the Institute of Plant Breeding at the University
of the Philippines is set to release a Bt eggplant to the market
next year with trials being conducted at the moment.
“The developing world is watching,” said Bruce
Chassy, a food science professor who has served on international
committees that have developed safety standards for GM foods.
“The Philippines has been a model for the developing
world. The country has good scientists working with professional
regulators who move slowly and carefully to good decisions,”
he said.
GM crops are developed by inserting a gene or organism in a
host plant to make the latter more resistant to certain pests
and diseases, which allow farmers to less use pesticides or
herbicides.
But critics of GM crops said more tests are needed before commercializing
such crops to make sure that these are safe for human consumption
over the long term.